MedPath

Novartis Pharma AG

🇦🇺Australia
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.novartis.com

Clinical Trials

2.1k

Active:1894
Completed:20

Trial Phases

5 Phases

Phase 1:1825
Phase 2:26
Phase 3:33
+2 more phases

Drug Approvals

57

SFDA:51
NMPA:6

Drug Approvals

Diclofenac Diethylamine

Product Name
双氯芬酸二乙胺
Approval Number
H20160583
Approval Date
Nov 7, 2016
NMPA

Diclofenac Diethylamine

Product Name
双氯芬酸二乙胺
Approval Number
H20160573
Approval Date
Nov 7, 2016
NMPA

Carbamazepine

Product Name
卡马西平
Approval Number
H20140872
Approval Date
Nov 25, 2014
NMPA

Carbamazepine

Product Name
卡马西平
Approval Number
H20140871
Approval Date
Nov 25, 2014
NMPA

Terbinafine Hydrochloride

Product Name
盐酸特比萘芬
Approval Number
H20140786
Approval Date
Oct 18, 2014
NMPA

Clomipramine Hydrochloride

Product Name
盐酸氯米帕明
Approval Number
H20140408
Approval Date
Jun 3, 2014
NMPA

Clinical Trials

Distribution across different clinical trial phases (1900 trials with phase data)• Click on a phase to view related trials

Phase 1
1825 (96.1%)
Phase 3
33 (1.7%)
Phase 2
26 (1.4%)
phase_1_2
9 (0.5%)
Phase 4
4 (0.2%)
Not Applicable
2 (0.1%)
1 (0.1%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.